10-Q Filing

SOLENO THERAPEUTICS INC CIK: 1484565 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001628280-17-011537`
Period End Date	20170930
Filing Date	20171114
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	capn-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 84 Cash Flow Statement 84

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.65M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.42M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$3.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.97M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.36M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.36M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$247.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.97M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$145.00K	USD	Point-in-time
Current assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$790.00K	USD	Point-in-time
Current assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$563.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.80M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.39M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$55.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$54.00K	USD	Point-in-time
Other intangible assets, net	`OtherIntangibleAssetsNet`	$19.35M	USD	Point-in-time
Other intangible assets, net	`OtherIntangibleAssetsNet`	-	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$126.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$126.00K	USD	Point-in-time
Long-term assets held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$458.00K	USD	Point-in-time
Long-term assets held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$1.58M	USD	Point-in-time
Total assets	`Assets`	$26.38M	USD	Point-in-time
Total assets	`Assets`	$5.57M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$642.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$411.00K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$1.05M	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$976.00K	USD	Point-in-time
Current liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$246.00K	USD	Point-in-time
Current liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$113.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.71M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.73M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.13M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$62.00K	USD	Point-in-time
Long-term liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	-	USD	Point-in-time
Long-term liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$81.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$2.13M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.17M	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 9,970,538 and 3,357,390 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively. (Note 14)	`CommonStockValue`	$10.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 9,970,538 and 3,357,390 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively. (Note 14)	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$101.74M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$132.15M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-108.95M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-98.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$23.21M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$3.44M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$5.57M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$26.38M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$708.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.05M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$982.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.96M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	-	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	-	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	-	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$26.00K	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.71M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.90M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.26M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.53M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$1.97M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$2.69M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$6.49M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$6.97M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.49M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.97M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-1.97M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.69M	USD	1 Quarter
Interest Income	`InterestIncomeOther`	$4.00K	USD	1 Quarter
Interest Income	`InterestIncomeOther`	-	USD	3 Qtrs
Interest Income	`InterestIncomeOther`	$7.00K	USD	3 Qtrs
Interest Income	`InterestIncomeOther`	-	USD	1 Quarter
Change in fair value of warrants liabilities income (expense)	`FairValueAdjustmentOfWarrants`	$29.00K	USD	3 Qtrs
Change in fair value of warrants liabilities income (expense)	`FairValueAdjustmentOfWarrants`	$-200.00K	USD	1 Quarter
Change in fair value of warrants liabilities income (expense)	`FairValueAdjustmentOfWarrants`	$-130.00K	USD	1 Quarter
Change in fair value of warrants liabilities income (expense)	`FairValueAdjustmentOfWarrants`	$-1.29M	USD	3 Qtrs
Cease-use expense	`GainLossOnContractTermination`	-	USD	1 Quarter
Cease-use expense	`GainLossOnContractTermination`	$3.00K	USD	3 Qtrs
Cease-use expense	`GainLossOnContractTermination`	$4.00K	USD	1 Quarter
Cease-use expense	`GainLossOnContractTermination`	$-94.00K	USD	3 Qtrs
Other expense	`OtherNonrecurringExpense`	-	USD	1 Quarter
Other expense	`OtherNonrecurringExpense`	$9.00K	USD	1 Quarter
Other expense	`OtherNonrecurringExpense`	$602.00K	USD	3 Qtrs
Other expense	`OtherNonrecurringExpense`	$26.00K	USD	3 Qtrs
Interest and other income (expense), net	`OtherNonoperatingIncomeExpense`	$138.00K	USD	1 Quarter
Interest and other income (expense), net	`OtherNonoperatingIncomeExpense`	$-621.00K	USD	3 Qtrs
Interest and other income (expense), net	`OtherNonoperatingIncomeExpense`	$191.00K	USD	1 Quarter
Interest and other income (expense), net	`OtherNonoperatingIncomeExpense`	$1.18M	USD	3 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-7.59M	USD	3 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-2.55M	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-5.32M	USD	3 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-1.78M	USD	1 Quarter
Operating loss	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-1.03M	USD	1 Quarter
Operating loss	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-4.14M	USD	3 Qtrs
Operating loss	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-973.00K	USD	1 Quarter
Operating loss	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-2.84M	USD	3 Qtrs
Loss on sale of assets	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$-208.00K	USD	1 Quarter
Loss on sale of assets	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	-	USD	3 Qtrs
Loss on sale of assets	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$-208.00K	USD	3 Qtrs
Loss on sale of assets	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	-	USD	1 Quarter
Total	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.24M	USD	1 Quarter
Total	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-4.14M	USD	3 Qtrs
Total	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-3.05M	USD	3 Qtrs
Total	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-973.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.64M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.45M	USD	3 Qtrs
Loss per common share from continuing operations, basic and diluted (Note 14) (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.85	USD	3 Qtrs
Loss per common share from continuing operations, basic and diluted (Note 14) (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.24	USD	1 Quarter
Loss per common share from continuing operations, basic and diluted (Note 14) (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.56	USD	1 Quarter
Loss per common share from continuing operations, basic and diluted (Note 14) (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-1.73	USD	3 Qtrs
Operating (in usd per share)	`DiscontinuedOperationIncomeLossfromDiscontinuedOperationOperatingActivitiesNetofTaxPerBasicandDilutedShare`	$-0.31	USD	1 Quarter
Operating (in usd per share)	`DiscontinuedOperationIncomeLossfromDiscontinuedOperationOperatingActivitiesNetofTaxPerBasicandDilutedShare`	$-0.09	USD	1 Quarter
Operating (in usd per share)	`DiscontinuedOperationIncomeLossfromDiscontinuedOperationOperatingActivitiesNetofTaxPerBasicandDilutedShare`	$-1.35	USD	3 Qtrs
Operating (in usd per share)	`DiscontinuedOperationIncomeLossfromDiscontinuedOperationOperatingActivitiesNetofTaxPerBasicandDilutedShare`	$-0.32	USD	3 Qtrs
Loss on sale of assets (in usd per share)	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	-	USD	1 Quarter
Loss on sale of assets (in usd per share)	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	-	USD	3 Qtrs
Loss on sale of assets (in usd per share)	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.02	USD	1 Quarter
Loss on sale of assets (in usd per share)	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.02	USD	3 Qtrs
Total (in usd per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.11	USD	1 Quarter
Total (in usd per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-1.35	USD	3 Qtrs
Total (in usd per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.34	USD	3 Qtrs
Total (in usd per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.31	USD	1 Quarter
Net loss per share common share, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.35	USD	1 Quarter
Net loss per share common share, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-1.19	USD	3 Qtrs
Net loss per share common share, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-3.08	USD	3 Qtrs
Net loss per share common share, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.87	USD	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.94M	shares	3 Qtrs
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.07M	shares	3 Qtrs
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.15M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.77M	shares	1 Quarter

Cash Flow Statement 84 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-10.64M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.45M	USD	3 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.24M	USD	1 Quarter
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-4.14M	USD	3 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-3.05M	USD	3 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-973.00K	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-7.59M	USD	3 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-2.55M	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-5.32M	USD	3 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-1.78M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.03M	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$206.00K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$226.00K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$855.00K	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$560.00K	USD	3 Qtrs
Loss on disposition of property & equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Loss on disposition of property & equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.00K	USD	3 Qtrs
Board fees paid with common stock	`OtherNoncashExpense`	$195.00K	USD	3 Qtrs
Board fees paid with common stock	`OtherNoncashExpense`	-	USD	3 Qtrs
Change in fair value of common stock warrants	`ChangeInFairValueOfCommonStockWarrants`	$29.00K	USD	3 Qtrs
Change in fair value of common stock warrants	`ChangeInFairValueOfCommonStockWarrants`	$-1.32M	USD	3 Qtrs
Non-cash expense of issuing shares to Aspire Capital	`NoncashExpenseOnSharesIssued`	-	USD	3 Qtrs
Non-cash expense of issuing shares to Aspire Capital	`NoncashExpenseOnSharesIssued`	$602.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-3.00K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$52.00K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-101.00K	USD	3 Qtrs
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	-	USD	3 Qtrs
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$49.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$336.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$232.00K	USD	3 Qtrs
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-74.00K	USD	3 Qtrs
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-166.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-20.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$52.00K	USD	3 Qtrs
Net cash used in continuing operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.64M	USD	3 Qtrs
Net cash used in continuing operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-5.96M	USD	3 Qtrs
Net cash used in discontinued operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-2.58M	USD	3 Qtrs
Net cash used in discontinued operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-4.85M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.22M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.81M	USD	3 Qtrs
Costs of Essentialis acquisition paid	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Costs of Essentialis acquisition paid	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$573.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.00K	USD	3 Qtrs
Net cash used in continuing investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-577.00K	USD	3 Qtrs
Net cash used in continuing investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-22.00K	USD	3 Qtrs
Net cash provided by (used for) discontinued investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-17.00K	USD	3 Qtrs
Net cash provided by (used for) discontinued investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$716.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$139.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-39.00K	USD	3 Qtrs
Redemption of Series A preferred stock in conjunction with issuance of Series B preferred stock	`PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock`	-	USD	3 Qtrs
Redemption of Series A preferred stock in conjunction with issuance of Series B preferred stock	`PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock`	$7.78M	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$10.00M	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$70.00K	USD	3 Qtrs
Net cash provided by continuing financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$10.00M	USD	3 Qtrs
Net cash provided by continuing financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$10.77M	USD	3 Qtrs
Net cash provided by discontinued financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Net cash provided by discontinued financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.77M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.00M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.92M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-80.00K	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.65M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.50M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.73M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.42M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.65M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.50M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.73M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.42M	USD	Point-in-time
Conversion of Series A preferred to common stock	`ConversionOfStockAmountIssued1`	$2.22M	USD	3 Qtrs
Conversion of Series A preferred to common stock	`ConversionOfStockAmountIssued1`	-	USD	3 Qtrs
Issuance of common stock in Essentialis acquisition	`StockIssued1`	-	USD	3 Qtrs
Issuance of common stock in Essentialis acquisition	`StockIssued1`	$18.76M	USD	3 Qtrs
Contingent consideration of Essentialis acquisition	`NoncashorPartNoncashAcquisitionContingentConsideration`	-	USD	3 Qtrs
Contingent consideration of Essentialis acquisition	`NoncashorPartNoncashAcquisitionContingentConsideration`	$1.09M	USD	3 Qtrs
Series B preferred transactions costs in accounts payable	`TransactionCostsIncludedinAccruedLiabilities`	-	USD	3 Qtrs
Series B preferred transactions costs in accounts payable	`TransactionCostsIncludedinAccruedLiabilities`	$52.00K	USD	3 Qtrs
Fixed asset purchases in accounts payable	`FairValueOfAssetsAcquired`	$11.00K	USD	3 Qtrs
Fixed asset purchases in accounts payable	`FairValueOfAssetsAcquired`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.